NDC 51662-1432
Dexamethasone Sodium Phosphate 4 mg per 1 mL injection, solution
On the label: HF Acquisition Co. LLC. DBA HealthFirst. It's repackaged: HF Acquisition Co. LLC. DBA HealthFirst rebottles it from AuroMedics Pharma LLC's NDC 55150-239.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Eugia Pharma Specialities Limited | Sangareddy, India | Makes it, tests it and packages it | Serious problems, FDA actionFeb 6, 2026 · 7 inspections, 2 with FDA action |
Repackaging site
- HF Acquisition Co LLC, Mukilteo, WA, United States · relabels it
Recalls
- May 23, 2024 · Class II · Eugia US LLC
Failed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec.
Lots: Lot#: 3DS23001, 3DS23004, Exp 6/30/2024; 3DS23009, 3DS23011, Exp 7/31/2024
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Dexamethasone: every company that makes it
- Form
- injection, solution, intra-articular; intralesional; intramuscular; intravenous; soft tissue
- Strength
- 4 mg per 1 mL
- Approval
- ANDA ANDA206781
- On the market since
- Dec 21, 2019
- Package NDCs
51662-1432-1- Official label
- DailyMed (National Library of Medicine), updated Jan 8, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?